慢性重型肝炎患者血清生化指标与预后的相关性研究(2)
第1页 |
参见附件。
[2] Georgej M,Webster,Stephanie R.Incubation phase of acute hepatitis B in man dynamic of celular immune mechanisms[J].Hepatology,2000,32(5):1117-1124.
[3] Yuen MF,Sablon E,Hui CK,et al.Pro9gnostic factors in severe exacerbation of chronic hepatitis B[J].clin Infect Dis,2003,36(8):979-984.
[4] 唐中權,郭静雯.重型肝炎的生化指标及治疗方案对患者预后的影响[J].中华现代内科学杂志,2005,2(11):1020-1021.
[5] Yang SS,Cheng KS,Lai YC,et al.Decreasing serum alpha-fetiorotein levels in predicting poor prognosis of acute hepatic failure in patients with chronic hepatms B[J].J Gastroenterol,2002,37(8):626.
[6] 陈美鸿,林庆东,吴多荣.血液淋巴细胞计数、HBV-DNA载量、血清总胆固醇对重型肝炎诊断及预后判断的价值[J].临床消化病杂志,2006,18(3):166-168.
[7] Choi J,Oh JH.Mechanisms of liver injury.Ⅲ.Oxidative stress in the pathogenesis of hepatitis C virus[J].Am J Physiol Gastrointest Liver Physiol,2006,290(5):847-851.
[8] Saxena A,Sun W,Luo C.Human serum butyrylcholinesterase:In vitro and in vivo stabilny,pharmacokinetics,and safety in mice[J].Chem Biol Interact,2005,(157-158):199.
[9] 韩志启,朱增红,冀宝剑.重症肝炎患者凝血酶原时间、前清蛋白、胆固醇、胆碱酯酶的观察[J].现代中西医结合杂志,2003,12(23):2591.
您现在查看是摘要介绍页,详见PDF附件。